Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Genetronics to begin phase II head and neck cancer trial in Canada

Jan. 22, 1998

T Cell Sciences and Walter Reed collaborate on inhibition of liposome-induced complement activation

Jan. 22, 1998

Repligen and Glaxo extend Glyceptor collaboration

Jan. 22, 1998

Dynavax and Vical crosslicense DNA immunization technology

Jan. 21, 1998

Ribozyme, Parke-Davis intend to collaborate

Jan. 20, 1998

Pharmacopeia achieves milestone in collaboration with Daiichi

Jan. 20, 1998

Lilly acquires rights to Sibia's drug discovery technology

Jan. 20, 1998

Lexicon and ZymoGenetics sign functional genomics agreement

Jan. 20, 1998

Inhale and Lilly to codevelop pulmonary delivery formulation

Jan. 20, 1998

Optex awarded Phase II SBIR grant

Jan. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...